Ordinatrix LLC

Ordinatrix builds on over a decade of development and refinement of the Nucleic Acid Programmable Protein Arrays (NAPPA) technology. Ordinatrix provides a customizable solution for analysis of the proteome with the commercial introduction of the Nucleic Acid Programmable Protein Arrays (NAPPA) platform. Our just-in-time protein production process allows us to provide customers with the screening of the complete human proteome comprising over 18,000 unique proteins, or selective target proteins of their choosing at the time of order. Ordinatrix holds exclusive worldwide licenses to the NAPPA technology through licensing agreements with Arizona State University.